Michael B. Maris, MD

Hematologist and medical oncologist, Director of Research, Colorado Blood Cancer Institute

location_city Colorado Blood Cancer Institute

22 years treating Acute Myeloid Leukemia

Clinical Expertise

Dr. Maris' current research interests are in further optimizing allogeneic hematopoietic transplantation for patients of all types as well as the development of novel drug and drug regimens for the treatment of the patients with acute myeloid leukemia. Dr. Maris has extensive experience as an investigator in multiple clinical trials and he has expertise in the treatment of patients with acute myeloid leukemia and aggressive lymphomas.